Literature DB >> 27832546

Large-Scale RNA Interference Screening to Identify Transcriptional Regulators of a Tumor Suppressor Gene.

Matteo Forloni1, Thuy Ho1, Lisha Sun1, Narendra Wajapeyee2.   

Abstract

RNA interference (RNAi) is a powerful research tool that can be used to silence the expression of a specific gene. In the past several years, RNAi has provided the opportunity to identify factors and pathways involved in complex biological processes by performing unbiased loss-of-function screens on a genome-wide scale. Here we describe a genome-wide RNAi screening strategy to identify factors that regulates epigenetic silencing of a specific tumor suppressor gene, using RASSF1A as an example. The approach we describe is a general RNAi screening strategy that can be applied to identify other factors that drive and/or maintain epigenetic modifications on specific genes, including cancer-related genes.

Entities:  

Keywords:  Epigenetic silencing; Positive-selection screen; RNA interference; shRNA; siRNA

Mesh:

Substances:

Year:  2017        PMID: 27832546      PMCID: PMC5340288          DOI: 10.1007/978-1-4939-6518-2_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

Review 1.  Genome-wide approaches for cancer gene discovery.

Authors:  Paul M Lizardi; Matteo Forloni; Narendra Wajapeyee
Journal:  Trends Biotechnol       Date:  2011-07-13       Impact factor: 19.536

2.  Second-generation shRNA libraries covering the mouse and human genomes.

Authors:  Jose M Silva; Mamie Z Li; Ken Chang; Wei Ge; Michael C Golding; Richard J Rickles; Despina Siolas; Guang Hu; Patrick J Paddison; Michael R Schlabach; Nihar Sheth; Jeff Bradshaw; Julia Burchard; Amit Kulkarni; Guy Cavet; Ravi Sachidanandam; W Richard McCombie; Michele A Cleary; Stephen J Elledge; Gregory J Hannon
Journal:  Nat Genet       Date:  2005-10-02       Impact factor: 38.330

3.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Authors:  R Dammann; C Li; J H Yoon; P L Chin; S Bates; G P Pfeifer
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 4.  Dissecting cancer pathways and vulnerabilities with RNAi.

Authors:  T F Westbrook; F Stegmeier; S J Elledge
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

Review 5.  Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer.

Authors:  J Mullenders; R Bernards
Journal:  Oncogene       Date:  2009-09-21       Impact factor: 9.867

Review 6.  Using functional genetics to understand breast cancer biology.

Authors:  Alan Ashworth; Rene Bernards
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

7.  Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.

Authors:  Rajendra Kumar Palakurthy; Narendra Wajapeyee; Manas K Santra; Claude Gazin; Ling Lin; Stephane Gobeil; Michael R Green
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.